Medicine and Dentistry
Heart Failure
100%
Ketone Bodies
42%
3 Hydroxybutyric Acid
42%
Cardiogenic Shock
37%
Heart Output
37%
Hemodynamic
35%
Placebo
32%
Positron Emission Tomography
28%
Infusion
25%
Glucose Uptake
24%
Heart Left Ventricle Ejection Fraction
23%
Carbon 13
21%
Myocardium
20%
Diabetes
20%
Cardiovascular Effect
20%
Pyruvic Acid
20%
Heart Muscle Oxygen Consumption
19%
Lactic Acid
18%
Fatty Acid
18%
Heart Failure with Reduced Ejection Fraction
17%
Ejection Fraction
17%
Echocardiography
17%
Patient with Type 2 Diabetes
15%
Exercise Test
14%
Blood Flow
14%
Liraglutide
14%
Maturity Onset Diabetes of the Young
13%
Heart Function
13%
Heart Muscle Metabolism
13%
Infective Endocarditis
12%
Heart Muscle Blood Flow
12%
Congestive Heart Failure
12%
Cardiac Magnetic Resonance Imaging
11%
Heart Left Ventricle Function
11%
Stroke Volume
11%
Cardiovascular System
11%
Ischemic Cardiomyopathy
11%
Disease
10%
Heart Muscle Contractility
10%
Carbon 11
10%
Magnetic Resonance Imaging
10%
Symptom
9%
Glycon
9%
Proteomics
9%
Advance Care Planning
9%
Aortic Valve Stenosis
9%
Continuous Positive Airway Pressure
9%
Diabetes Mellitus
8%
Acetic Acid
7%
Radioactive Tracer
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
88%
Ketone Bodies
35%
3 Hydroxybutyric Acid
35%
Placebo
24%
Liraglutide
18%
Cardiogenic Shock
18%
Non Insulin Dependent Diabetes Mellitus
17%
Pyruvic Acid
14%
Porcine Model
14%
Fatty Acid
14%
Heart Failure with Reduced Ejection Fraction
11%
Bacterial Endocarditis
11%
Carbon 13
10%
All Cause Mortality
9%
Heart Muscle Ischemia
9%
Beta Adrenergic Receptor Blocking Agent
9%
Carbon 11
8%
Lactic Acid
7%
Cohort Study
7%
Normal Human
7%
Ischemia
7%
Ischemic Cardiomyopathy
6%
Tracer
6%
Combination Therapy
6%
Diabetes Mellitus
6%
1,3 Butanediol
5%
Systolic Heart Failure
5%
Glucagon Like Peptide 1 Receptor Agonist
5%
Keyphrases
Cardiovascular Effects
14%
Patients with Heart Failure
14%
Ketone Bodies
9%
3-hydroxybutyrate
9%
Heart Failure with Preserved Ejection Fraction (HFpEF)
9%
Cardiac Output
9%
Left Ventricular Ejection Fraction
7%
Heart Failure Patients
7%
Lactate
7%
Metabolic Profiling
5%
Free Fatty Acids
5%
Chronic Heart Failure
5%
Glucagon-like
5%
